Editorials

CCRL2 and who? An important driver in TP53-mutant myeloid leukemias

Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637
Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637
Haematologica Early view Sep 11, 2025 https://doi.org/10.3324/haematol.2025.288631